On July 4th, Shengda Bio-pharm and Meinong Bio-pharmaceuticals fell more than 5%, while Zhejiang Anglikang Pharmaceutical, Tibet Weixinkang Pharmaceutical, Hubei Guangji Pharmaceutical and others weakened.
A股维生素概念股持续走低 圣达生物跌超5%
A-share vitamin concept stock continued to decline, zhejiang shengda bio-pharm fell more than 5%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.